Sutro Biopharma (STRO) EPS (Diluted) (2019 - 2026)

Sutro Biopharma (STRO) EPS (Diluted) (2019 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 4.31
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 12.23
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 7.33
4 Revolution Medicines 43.64 Bn 43.64 Bn - -3.06
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 0.16
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 0.00
7 Royalty Pharma 33.72 Bn 35.84 Bn - 0.15
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 1.19
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -0.06
10 Sutro Biopharma 339.58 Mn 175.24 Mn - -2.33

Historic Data

Download Data
DateValue
Jun 30, 2026 -4.53
Dec 31, 2025 -5.50
Sep 30, 2025 -6.70
Jun 30, 2025 -1.36
Mar 31, 2025 -8.14
Dec 31, 2024 -9.43
Sep 30, 2024 -5.95
Jun 30, 2024 -5.91
Mar 31, 2024 -9.47
Dec 31, 2023 5.16
Sep 30, 2023 -8.13
Jun 30, 2023 -6.38
Mar 31, 2023 -8.52
Dec 31, 2022 -6.82
Sep 30, 2022 -3.72
Jun 30, 2022 -5.54
Mar 31, 2022 -8.41
Dec 31, 2021 -8.27
Sep 30, 2021 -6.69
Jun 30, 2021 -1.33